Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Masked, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects With Active Noninfectious Uveitis Involving the Intermediate and/or Posterior Segments of the Eye

NCT01243983 is registered in ClinicalTrials.gov with Lux Biosciences, Inc. as lead sponsor.

NCT NCT01243983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01243983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Masked, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects With Active Noninfectious Uveitis Involving the Intermediate and/or Posterior Segments of the Eye
Lead sponsor
Lux Biosciences, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
December 31, 2012
Enrollment
155 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

noninfectious uveitis